Increase of number of shares and votes in Vicore Pharma
As previously announced, the Company’s board of directors resolved on a directed share issue of 11,200,000 shares at a subscription price of SEK 30.00 per share on February 9, 2021. The directed share issue was approved at an Extraordinary General Meeting held on March 5, 2021. Through the share issue, Vicore received issue proceeds of approximately 336 MSEK before issue costs.
As of today, the total number of registered and outstanding shares and votes of Vicore Pharma amounts to 71,760,293. Furthermore, the registered share capital amounts to SEK 35,880,146.
For further information, please contact:
Carl-Johan Dalsgaard, CEO, tel: +46 70 975 98 63, firstname.lastname@example.org
Hans Jeppsson, CFO, tel: +46 70 553 14 65, email@example.com
This information is information that Vicore Pharma Holding AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact persons set out above, on March 31, 2021 at 09:00 CEST.